C19orf10 Antikörper
Kurzübersicht für C19orf10 Antikörper (ABIN6260360)
Target
Alle C19orf10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- C19orf10 Antibody detects endogenous levels of total C19orf10
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus)
-
Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogen
- A synthesized peptide derived from human C19orf10
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C.Stable for 12 months from date of receipt
-
Haltbarkeit
- 12 months
-
-
- C19orf10 (Chromosome 19 Open Reading Frame 10 (C19orf10))
-
Andere Bezeichnung
- C19orf10
-
Hintergrund
-
Description: Bone marrow-derived monocyte and paracrine-acting protein that promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction (MI). Stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1-mediated signaling pathway. Inhibits cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway (By similarity). Involved in endothelial cell proliferation and angiogenesis (PubMed:25581518).
Gene: MYDGF
-
Molekulargewicht
- 19kDa
-
Gen-ID
- 56005
-
UniProt
- Q969H8
-
Pathways
- ER-Nucleus Signaling
Target
-